We're pleased to announce, hot off the press, two EASL-endorsed publications, communicating complex COVID-19 information and providing support to patients and their associations.
Care of Patients with Rare Liver Diseases during the Covid-19 Pandemic (lay summary)
COVID-19 Toolkit for liver patient organisations
These publications were written as a collaboration among patient organisations, advisory groups, and EASL board members. They are based on the "EASL-ESCMID Position Paper", originally published in the Journal of Hepatology.
Register now for
The Digital International Liver Congress™ 2020
Online registration for new participants is now open. Please note that this is only for new registrations. If you have already registered, please disregard this information. You are welcome to browse the programme, to enjoy a taste of what is to come.
Save the date for
The International Liver Congress™ 2021
In 2021, we will be bringing the members of our community together again in person, around the same table, to explore how to tackle liver disease with a multidisciplinary approach.
EASL-supported COVID-HEP registry informs research
Hear how this registry is informing research right now. Listen to Dr Thomas Marjot, University of Oxford, UK, presenting on "COVID-19 in patients with autoimmune liver disease and cirrhosis: data from the COVID-Hep and SECURE-cirrhosis registries".
Watch from 36'35" onwards in this video "Webinar on COVID-19 and Rare Liver diseases", held by the European Reference Networks of the European Commission.
ESOT-ELITA, EASL, and ILTS speakers came together on 13 July to discuss the effects of the pandemic on liver transplantation in Europe and in the United States. This free webinar also explores the response of medical societies regarding education.
Applications open for short-term training fellowship
The Andrew K. Burroughs short-term fellowship programme is intended to support postgraduate investigators (basic and clinical), needing to spend 3-6 months at a foreign institution to accomplish a focussed research project.
EASL recognises excellence within the hepatology community.
Add your signature to eliminate viral hepatitis by 2030
World Hepatitis Day is on 28 July 2020. Join EASL in signing the NO-Hep open letter to ministries of health worldwide, urging them to act now to eliminate viral hepatitis by 2030. They have a decade left to fulfil their promise. The World Hepatitis Alliance is aiming to collect 1,000 signatures.
Stay tuned for more news and activities around World Hepatitis Day.
PREDICT Study findings published in the Journal of Hepatology
Findings from the PREDICT Study, led by the European Foundation for the Study of Chronic Liver Failure (EF Clif) in Barcelona, have identified three clinical courses in acute decompensated cirrhosis, after hospital admission.
Hot off the press! Keep abreast of the latest scientific developments in the latest issues of our monthly EASL journals.
Being an EASL member brings you: online subscription to the Journal of Hepatology, and a 50% discount on open-access publication fees for JHEP Reports.
Journal of Hepatology Volume 73, Issue 2
JHEP Reports Volume 2, Issue 3
Download the EASL app
Access event info, EASL Campus and stay informed with the latest messages and news.
For the latest news on COVID-19 and liver disease, follow us on Twitter
